Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Five-hundred life-saving interventions and their cost-effectiveness.

Tengs TO, Adams ME, Pliskin JS, Safran DG, Siegel JE, Weinstein MC, Graham JD.

Risk Anal. 1995 Jun;15(3):369-90.

PMID:
7604170
2.
3.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
4.

Cost-effectiveness analysis of helicopter EMS for trauma patients.

Gearhart PA, Wuerz R, Localio AR.

Ann Emerg Med. 1997 Oct;30(4):500-6. Review.

PMID:
9326865
5.

When is critical care medicine cost-effective? A systematic review of the cost-effectiveness literature.

Talmor D, Shapiro N, Greenberg D, Stone PW, Neumann PJ.

Crit Care Med. 2006 Nov;34(11):2738-47. Review.

PMID:
16957636
6.
7.

The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.

Fox M, Mealing S, Anderson R, Dean J, Stein K, Price A, Taylor RS.

Health Technol Assess. 2007 Nov;11(47):iii-iv, ix-248. Review.

8.

The socioeconomic burden of fractures: today and in the 21st century.

Johnell O.

Am J Med. 1997 Aug 18;103(2A):20S-25S; discussion 25S-26S. Review.

PMID:
9302894
9.

When does quality-adjusting life-years matter in cost-effectiveness analysis?

Chapman RH, Berger M, Weinstein MC, Weeks JC, Goldie S, Neumann PJ.

Health Econ. 2004 May;13(5):429-36. Review.

PMID:
15127423
10.

Cost effectiveness of statins in coronary heart disease.

Franco OH, Peeters A, Looman CW, Bonneux L.

J Epidemiol Community Health. 2005 Nov;59(11):927-33. Review.

11.

Efficacy and cost-effectiveness of the first generation of HIV prevention interventions for people with severe and persistent mental illness.

Johnson-Masotti AP, Weinhardt LS, Pinkerton SD, Otto-Salaj LL.

J Ment Health Policy Econ. 2003 Mar;6(1):23-35. Review.

PMID:
14578545
12.

Measuring cost-effectiveness of surgical procedures.

Subak LL, Caughey AB.

Clin Obstet Gynecol. 2000 Sep;43(3):551-60. Review.

PMID:
10949758
13.

Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.

Shepherd J, Jones J, Frampton GK, Tanajewski L, Turner D, Price A.

Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. Review.

14.

An overview of economic evaluations for drugs used in rheumatoid arthritis : focus on tumour necrosis factor-alpha antagonists.

Bansback NJ, Regier DA, Ara R, Brennan A, Shojania K, Esdaile JM, Anis AH, Marra CA.

Drugs. 2005;65(4):473-96. Review.

PMID:
15733011
16.

A clinician's guide to cost-effectiveness analysis.

Detsky AS, Naglie IG.

Ann Intern Med. 1990 Jul 15;113(2):147-54. Review.

PMID:
2113784
17.

Evaluating the cost-effectiveness of clinical and public health measures.

Graham JD, Corso PS, Morris JM, Segui-Gomez M, Weinstein MC.

Annu Rev Public Health. 1998;19:125-52. Review.

PMID:
9611615
18.

Placing a value on life and limb: the role of the informed consumer.

Eastaugh SR.

Health Matrix. 1983 Winter;1(1):5-21. Review.

PMID:
10310247
19.

Evolution of trauma and trauma research.

Shires GT.

J Trauma. 1990 Dec;30(12 Suppl):S107-15. Review. No abstract available.

PMID:
2254969

Supplemental Content

Support Center